390 related articles for article (PubMed ID: 30119678)
1. Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.
Tivari S; Lu H; Dasgupta T; De Lorenzo MS; Wieder R
Cell Commun Signal; 2018 Aug; 16(1):48. PubMed ID: 30119678
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of estrogen receptor and modulation of growth of breast cancer cell lines mediated by paracrine stromal cell signals.
Huang J; Woods P; Normolle D; Goff JP; Benos PV; Stehle CJ; Steinman RA
Breast Cancer Res Treat; 2017 Jan; 161(2):229-243. PubMed ID: 27853906
[TBL] [Abstract][Full Text] [Related]
3. Angiopoietin-2 promotes ER+ breast cancer cell survival in bone marrow niche.
Han HH; Kim BG; Lee JH; Kang S; Kim JE; Cho NH
Endocr Relat Cancer; 2016 Aug; 23(8):609-23. PubMed ID: 27353038
[TBL] [Abstract][Full Text] [Related]
4. Senescence-associated IL-6 and IL-8 cytokines induce a self- and cross-reinforced senescence/inflammatory milieu strengthening tumorigenic capabilities in the MCF-7 breast cancer cell line.
Ortiz-Montero P; Londoño-Vallejo A; Vernot JP
Cell Commun Signal; 2017 May; 15(1):17. PubMed ID: 28472950
[TBL] [Abstract][Full Text] [Related]
5. An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation.
Tivari S; Korah R; Lindy M; Wieder R
J Vis Exp; 2015 Jun; (100):e52672. PubMed ID: 26168083
[TBL] [Abstract][Full Text] [Related]
6. Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling.
Hamel KM; King CT; Cavalier MB; Liimatta KQ; Rozanski GL; King TA; Lam M; Bingham GC; Byrne CE; Xing D; Collins-Burow BM; Burow ME; Belgodere JA; Bratton MR; Bunnell BA; Martin EC
Stem Cells Dev; 2022 Oct; 31(19-20):604-620. PubMed ID: 35579936
[TBL] [Abstract][Full Text] [Related]
7. A Senescence-Associated Secretory Phenotype of Bone Marrow Mesenchymal Stem Cells Inhibits the Viability of Breast Cancer Cells.
Li M; Liu JX; Ma B; Liu JY; Chen J; Jin F; Hu CH; Xu HK; Zheng CX; Hou R
Stem Cell Rev Rep; 2024 May; 20(4):1093-1105. PubMed ID: 38457059
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
9. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
[TBL] [Abstract][Full Text] [Related]
10. Adipocyte hypoxia promotes epithelial-mesenchymal transition-related gene expression and estrogen receptor-negative phenotype in breast cancer cells.
Yao-Borengasser A; Monzavi-Karbassi B; Hedges RA; Rogers LJ; Kadlubar SA; Kieber-Emmons T
Oncol Rep; 2015 Jun; 33(6):2689-94. PubMed ID: 25823469
[TBL] [Abstract][Full Text] [Related]
11. Conditioned medium from stimulated macrophages inhibits growth but induces an inflammatory phenotype in breast cancer cells.
Song W; Thakor P; Vesey DA; Gobe GC; Morais C
Biomed Pharmacother; 2018 Oct; 106():247-254. PubMed ID: 29966967
[TBL] [Abstract][Full Text] [Related]
12. Dormancy and growth of metastatic breast cancer cells in a bone-like microenvironment.
Sosnoski DM; Norgard RJ; Grove CD; Foster SJ; Mastro AM
Clin Exp Metastasis; 2015 Apr; 32(4):335-44. PubMed ID: 25749879
[TBL] [Abstract][Full Text] [Related]
13. Estrogen promotes reversible epithelial-to-mesenchymal-like transition and collective motility in MCF-7 breast cancer cells.
Planas-Silva MD; Waltz PK
J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):11-21. PubMed ID: 17197171
[TBL] [Abstract][Full Text] [Related]
14. Fludioxonil induced the cancer growth and metastasis via altering epithelial-mesenchymal transition via an estrogen receptor-dependent pathway in cellular and xenografted breast cancer models.
Go RE; Kim CW; Jeon SY; Byun YS; Jeung EB; Nam KH; Choi KC
Environ Toxicol; 2017 Apr; 32(4):1439-1454. PubMed ID: 27539251
[TBL] [Abstract][Full Text] [Related]
15. Integrin alpha5beta1 promotes survival of growth-arrested breast cancer cells: an in vitro paradigm for breast cancer dormancy in bone marrow.
Korah R; Boots M; Wieder R
Cancer Res; 2004 Jul; 64(13):4514-22. PubMed ID: 15231661
[TBL] [Abstract][Full Text] [Related]
16. Impact of stromal cell components of tumor microenvironment on epithelial-mesenchymal transition in breast cancer cells.
Bezdenezhnykh N; Semesiuk N; Lykhova O; Zhylchuk V; Kudryavets Y
Exp Oncol; 2014 Jun; 36(2):72-8. PubMed ID: 24980759
[TBL] [Abstract][Full Text] [Related]
17. Kaempferol, a phytoestrogen, suppressed triclosan-induced epithelial-mesenchymal transition and metastatic-related behaviors of MCF-7 breast cancer cells.
Lee GA; Choi KC; Hwang KA
Environ Toxicol Pharmacol; 2017 Jan; 49():48-57. PubMed ID: 27902959
[TBL] [Abstract][Full Text] [Related]
18. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
19. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory cytokines prime adipose tissue mesenchymal stem cells to enhance malignancy of MCF-7 breast cancer cells via transforming growth factor-β1.
Trivanović D; Jauković A; Krstić J; Nikolić S; Okić Djordjević I; Kukolj T; Obradović H; Mojsilović S; Ilić V; Santibanez JF; Bugarski D
IUBMB Life; 2016 Mar; 68(3):190-200. PubMed ID: 26805406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]